<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02614625</url>
  </required_header>
  <id_info>
    <org_study_id>OCTComparisonstudy1.1</org_study_id>
    <nct_id>NCT02614625</nct_id>
  </id_info>
  <brief_title>Spectral-domain Optical Coherence Tomography of the Eye</brief_title>
  <official_title>A Prospective, Comparative, Observational Study on Spectral-domain Optical Coherence Tomography of the Eye</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Augenabteilung Allgemeines Krankenhaus Linz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Augenabteilung Allgemeines Krankenhaus Linz</source>
  <brief_summary>
    <textblock>
      An increasing number of clinical studies on SD-OCT of ocular pathologies and potential new&#xD;
      clinical applications has recently been published in the peer-reviewed literature. However,&#xD;
      the successful use of SD-OCT in routine clinical use depends upon the diagnostic sensitivity,&#xD;
      biometric accuracy and reliability of the SD-OCT machines. This prospective, comparative,&#xD;
      observational study aims to evaluate the imaging quality and diagnostic performance of two&#xD;
      commercially available SD-OCT machines for both the anterior and posterior segment of the&#xD;
      eye.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity as the proportion of anatomical structures that are detectable with the two instruments</measure>
    <time_frame>6 months</time_frame>
    <description>Anatomical structures include e.g. sublayers of the cornea, sublayers of the retina, retinal vessels etc.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Corneal sublayer thickness (µm) and retinal sublayer thickness (µm) obtained with the two study instruments</measure>
    <time_frame>6 months</time_frame>
    <description>Comparability is analyzed between various biometric values obtained with the two instruments and typical indices of comparability are produced (e.g. intraclass correlation coefficient)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal sublayer thickness and retinal sublayer thickness obtained with the two study instruments</measure>
    <time_frame>6 months</time_frame>
    <description>Repeatability for various biometric values obtained with the two instruments is analyzed and typical indices of repeatability are produced (e.g. coefficient of variation)</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cornea</condition>
  <condition>Retina</condition>
  <condition>Refractive Surgery</condition>
  <condition>Macular Edema</condition>
  <condition>Diabetes</condition>
  <condition>Diabetic Macular Edema</condition>
  <arm_group>
    <arm_group_label>Normal subjects</arm_group_label>
    <description>Patient with healthy, normal eyes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eyes with corneal disease</arm_group_label>
    <description>Subjects that have any of the following conditions&#xD;
Corneal dystrophy or degeneration&#xD;
Corneal scarring&#xD;
Corneal ulcer&#xD;
Corneal injury&#xD;
Keratoconus&#xD;
Patients who had undergone corneal surgery&#xD;
Patients with other corneal disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eyes with retinal disease</arm_group_label>
    <description>Subjects that have any of the following conditions:&#xD;
Diabetic macular edema&#xD;
Cystoid macular edema&#xD;
Age related macular degeneration&#xD;
Retinal vascular disorders (e.g. retinal artery occlusion)&#xD;
Epiretinal membrane&#xD;
Choroidal nevus&#xD;
Macular hole&#xD;
Patients who had undergone retinal surgery&#xD;
Patients with other retinal disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eyes with glaucoma</arm_group_label>
    <description>Eyes diagnosed with glaucoma of any type and any stage</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        200 eyes of 100 patients will be included.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 21 and older&#xD;
&#xD;
          -  Normal eyes or&#xD;
&#xD;
          -  Eyes with corneal disease:&#xD;
&#xD;
        Subjects that have any of the following conditions&#xD;
&#xD;
          1. Corneal dystrophy or degeneration&#xD;
&#xD;
          2. Corneal scarring&#xD;
&#xD;
          3. Corneal ulcer&#xD;
&#xD;
          4. Corneal injury&#xD;
&#xD;
          5. Keratoconus&#xD;
&#xD;
          6. Patients who had undergone corneal surgery&#xD;
&#xD;
          7. Patients with other corneal disease or - Eyes with retinal disease:&#xD;
&#xD;
        Subjects that have any of the following conditions:&#xD;
&#xD;
          1. Diabetic macular edema&#xD;
&#xD;
          2. Cystoid macular edema&#xD;
&#xD;
          3. Age related macular degeneration&#xD;
&#xD;
          4. Retinal vascular disorders (e.g. retinal artery occlusion)&#xD;
&#xD;
          5. Epiretinal membrane&#xD;
&#xD;
          6. Choroidal nevus&#xD;
&#xD;
          7. Macular hole&#xD;
&#xD;
          8. Patients who had undergone retinal surgery&#xD;
&#xD;
          9. Patients with other retinal disease or&#xD;
&#xD;
               -  Eyes with glaucoma&#xD;
&#xD;
               -  Normal findings in the medical history and physical examination unless the&#xD;
                  investigator considers an abnormality to be clinically irrelevant.&#xD;
&#xD;
        AND&#xD;
&#xD;
        - Written informed consent prior to recruitment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Any of the following will exclude a subject from the study:&#xD;
&#xD;
          -  Patients who are not able to cooperate or with insufficient ability to fixate (tremor,&#xD;
             nystagmus)&#xD;
&#xD;
          -  Pregnancy (pregnancy test will be taken in women of reproductive age before enrolment&#xD;
             into the trial)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthias Bolz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AKh Linz, Augenabteilung</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nikolaus Luft, MD</last_name>
    <phone>+43 732 7806</phone>
    <phone_ext>1050</phone_ext>
    <email>nikolaus.luft@akh.linz.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>AKh Linz</name>
      <address>
        <city>Linz</city>
        <state>Oberösterreich</state>
        <zip>4021</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <study_first_submitted>October 12, 2015</study_first_submitted>
  <study_first_submitted_qc>November 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2015</study_first_posted>
  <last_update_submitted>November 22, 2015</last_update_submitted>
  <last_update_submitted_qc>November 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Edema</mesh_term>
    <mesh_term>Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

